UTHR Annual Cost Of Goods Sold
$257.50 M
+$105.90 M+69.85%
31 December 2023
Summary:
As of January 19, 2025, UTHR annual cost of goods sold is $257.50 million, with the most recent change of +$105.90 million (+69.85%) on December 31, 2023. During the last 3 years, it has risen by +$149.40 million (+138.21%). UTHR annual cost of goods sold is now at all-time high.UTHR Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Quarterly Cost Of Goods Sold
$83.10 M
+$5.30 M+6.81%
30 September 2024
Summary:
As of January 19, 2025, UTHR quarterly cost of goods sold is $83.10 million, with the most recent change of +$5.30 million (+6.81%) on September 30, 2024. Over the past year, it has increased by +$13.00 million (+18.54%). UTHR quarterly cost of goods sold is now at all-time high.UTHR Quarterly Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR TTM Cost Of Goods Sold
$304.80 M
+$13.00 M+4.46%
30 September 2024
Summary:
As of January 19, 2025, UTHR TTM cost of goods sold is $304.80 million, with the most recent change of +$13.00 million (+4.46%) on September 30, 2024. Over the past year, it has increased by +$59.50 million (+24.26%). UTHR TTM cost of goods sold is now at all-time high.UTHR TTM Cost Of Goods Sold Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Cost Of Goods Sold Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +69.8% | +18.5% | +24.3% |
| 3 y3 years | +138.2% | +18.5% | +24.3% |
| 5 y5 years | +29.6% | +255.1% | +172.4% |
UTHR Cost Of Goods Sold High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +110.2% | at high | +220.8% | at high | +158.5% |
| 5 y | 5-year | at high | +138.2% | at high | +261.3% | at high | +198.5% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% | at high | >+9999.0% |
United Therapeutics Cost Of Goods Sold History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $83.10 M(+6.8%) | $304.80 M(+4.5%) |
| June 2024 | - | $77.80 M(+6.7%) | $291.80 M(+4.9%) |
| Mar 2024 | - | $72.90 M(+2.7%) | $278.10 M(+8.0%) |
| Dec 2023 | $257.50 M(+69.9%) | $71.00 M(+1.3%) | $257.50 M(+5.0%) |
| Sept 2023 | - | $70.10 M(+9.4%) | $245.30 M(+15.5%) |
| June 2023 | - | $64.10 M(+22.6%) | $212.40 M(+19.3%) |
| Mar 2023 | - | $52.30 M(-11.1%) | $178.00 M(+17.4%) |
| Dec 2022 | $151.60 M(+23.8%) | $58.80 M(+58.1%) | $151.60 M(+19.0%) |
| Sept 2022 | - | $37.20 M(+25.3%) | $127.40 M(+8.1%) |
| June 2022 | - | $29.70 M(+14.7%) | $117.90 M(-6.0%) |
| Mar 2022 | - | $25.90 M(-25.1%) | $125.40 M(+2.4%) |
| Dec 2021 | $122.50 M(+13.3%) | $34.60 M(+24.9%) | $122.50 M(-0.2%) |
| Sept 2021 | - | $27.70 M(-25.5%) | $122.70 M(+3.1%) |
| June 2021 | - | $37.20 M(+61.7%) | $119.00 M(+10.5%) |
| Mar 2021 | - | $23.00 M(-33.9%) | $107.70 M(-0.4%) |
| Dec 2020 | $108.10 M(-8.1%) | $34.80 M(+45.0%) | $108.10 M(+5.9%) |
| Sept 2020 | - | $24.00 M(-7.3%) | $102.10 M(-8.1%) |
| June 2020 | - | $25.90 M(+10.7%) | $111.10 M(-0.7%) |
| Mar 2020 | - | $23.40 M(-18.8%) | $111.90 M(-4.8%) |
| Dec 2019 | $117.60 M(-40.8%) | $28.80 M(-12.7%) | $117.60 M(-2.6%) |
| Sept 2019 | - | $33.00 M(+23.6%) | $120.70 M(-13.5%) |
| June 2019 | - | $26.70 M(-8.2%) | $139.60 M(-20.0%) |
| Mar 2019 | - | $29.10 M(-8.8%) | $174.60 M(-12.1%) |
| Dec 2018 | $198.70 M(+88.0%) | $31.90 M(-38.5%) | $198.70 M(-9.6%) |
| Sept 2018 | - | $51.90 M(-15.9%) | $219.80 M(+17.3%) |
| June 2018 | - | $61.70 M(+16.0%) | $187.40 M(+29.6%) |
| Mar 2018 | - | $53.20 M(+0.4%) | $144.60 M(+36.8%) |
| Dec 2017 | $105.70 M(+45.4%) | $53.00 M(+171.8%) | $105.70 M(+30.3%) |
| Sept 2017 | - | $19.50 M(+3.2%) | $81.10 M(-4.8%) |
| June 2017 | - | $18.90 M(+32.2%) | $85.20 M(-1.3%) |
| Mar 2017 | - | $14.30 M(-49.6%) | $86.30 M(+18.7%) |
| Dec 2016 | $72.70 M(+5.4%) | $28.40 M(+20.3%) | $72.70 M(+4.5%) |
| Sept 2016 | - | $23.60 M(+18.0%) | $69.60 M(+31.6%) |
| June 2016 | - | $20.00 M(+2757.1%) | $52.90 M(+8.2%) |
| Mar 2016 | - | $700.00 K(-97.2%) | $48.90 M(-29.1%) |
| Dec 2015 | $69.00 M(-45.2%) | $25.30 M(+266.7%) | $69.00 M(+16.0%) |
| Sept 2015 | - | $6.90 M(-56.9%) | $59.49 M(-36.3%) |
| June 2015 | - | $16.00 M(-23.1%) | $93.39 M(-19.6%) |
| Mar 2015 | - | $20.80 M(+31.8%) | $116.10 M(-7.8%) |
| Dec 2014 | $125.90 M(-4.0%) | $15.79 M(-61.3%) | $125.90 M(-15.4%) |
| Sept 2014 | - | $40.80 M(+5.4%) | $148.89 M(+7.3%) |
| June 2014 | - | $38.71 M(+26.5%) | $138.80 M(+4.8%) |
| Mar 2014 | - | $30.60 M(-21.1%) | $132.41 M(+1.0%) |
| Dec 2013 | $131.13 M(+9.9%) | $38.78 M(+26.2%) | $131.13 M(+0.9%) |
| Sept 2013 | - | $30.72 M(-5.0%) | $130.01 M(+2.2%) |
| June 2013 | - | $32.32 M(+10.3%) | $127.27 M(+2.2%) |
| Mar 2013 | - | $29.31 M(-22.2%) | $124.58 M(+4.4%) |
| Dec 2012 | $119.30 M | $37.66 M(+34.7%) | $119.30 M(+11.5%) |
| Sept 2012 | - | $27.97 M(-5.6%) | $106.96 M(+5.2%) |
| June 2012 | - | $29.63 M(+23.3%) | $101.67 M(+9.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2012 | - | $24.03 M(-5.1%) | $93.20 M(+4.8%) |
| Dec 2011 | $88.90 M(+31.4%) | $25.33 M(+11.7%) | $88.90 M(+8.3%) |
| Sept 2011 | - | $22.68 M(+7.2%) | $82.11 M(+3.2%) |
| June 2011 | - | $21.16 M(+7.2%) | $79.59 M(+8.0%) |
| Mar 2011 | - | $19.74 M(+6.5%) | $73.69 M(+7.0%) |
| Dec 2010 | $67.67 M(+49.3%) | $18.54 M(-8.0%) | $68.84 M(+7.9%) |
| Sept 2010 | - | $20.16 M(+32.1%) | $63.80 M(+13.1%) |
| June 2010 | - | $15.26 M(+2.5%) | $56.40 M(+10.1%) |
| Mar 2010 | - | $14.89 M(+10.3%) | $51.22 M(+13.0%) |
| Dec 2009 | $45.32 M(+50.7%) | $13.50 M(+5.8%) | $45.32 M(+13.5%) |
| Sept 2009 | - | $12.76 M(+26.5%) | $39.93 M(+14.4%) |
| June 2009 | - | $10.08 M(+12.2%) | $34.92 M(+8.6%) |
| Mar 2009 | - | $8.99 M(+10.8%) | $32.17 M(+7.0%) |
| Dec 2008 | $30.07 M(+35.1%) | $8.11 M(+4.7%) | $30.07 M(+6.2%) |
| Sept 2008 | - | $7.74 M(+5.6%) | $28.32 M(+5.9%) |
| June 2008 | - | $7.33 M(+6.5%) | $26.74 M(+8.0%) |
| Mar 2008 | - | $6.89 M(+8.3%) | $24.75 M(+11.2%) |
| Dec 2007 | $22.26 M(+30.7%) | $6.36 M(+3.1%) | $22.26 M(+7.8%) |
| Sept 2007 | - | $6.17 M(+15.4%) | $20.66 M(+10.8%) |
| June 2007 | - | $5.34 M(+21.5%) | $18.64 M(+6.3%) |
| Mar 2007 | - | $4.40 M(-7.5%) | $17.55 M(+3.0%) |
| Dec 2006 | $17.03 M(+38.3%) | $4.75 M(+14.4%) | $17.03 M(+10.4%) |
| Sept 2006 | - | $4.15 M(-2.1%) | $15.43 M(+4.9%) |
| June 2006 | - | $4.24 M(+9.5%) | $14.71 M(+7.8%) |
| Mar 2006 | - | $3.88 M(+23.0%) | $13.64 M(+10.7%) |
| Dec 2005 | $12.31 M(+49.3%) | $3.15 M(-8.1%) | $12.31 M(+7.9%) |
| Sept 2005 | - | $3.43 M(+8.1%) | $11.41 M(+12.5%) |
| June 2005 | - | $3.17 M(+24.3%) | $10.14 M(+12.6%) |
| Mar 2005 | - | $2.56 M(+13.5%) | $9.01 M(+9.2%) |
| Dec 2004 | $8.25 M(+21.6%) | $2.25 M(+4.3%) | $8.25 M(+13.4%) |
| Sept 2004 | - | $2.16 M(+5.7%) | $7.28 M(+5.9%) |
| June 2004 | - | $2.04 M(+13.8%) | $6.87 M(+0.3%) |
| Mar 2004 | - | $1.79 M(+40.2%) | $6.85 M(+1.0%) |
| Dec 2003 | $6.78 M(+24.3%) | $1.28 M(-27.0%) | $6.78 M(-3.1%) |
| Sept 2003 | - | $1.75 M(-13.2%) | $7.00 M(+7.3%) |
| June 2003 | - | $2.02 M(+16.8%) | $6.52 M(+1.7%) |
| Mar 2003 | - | $1.73 M(+15.5%) | $6.42 M(+17.6%) |
| Dec 2002 | $5.46 M(+73.9%) | $1.50 M(+17.5%) | $5.46 M(+15.9%) |
| Sept 2002 | - | $1.27 M(-33.4%) | $4.71 M(+9.7%) |
| June 2002 | - | $1.91 M(+148.4%) | $4.29 M(+38.3%) |
| Mar 2002 | - | $770.00 K(+3.0%) | $3.10 M(+25.3%) |
| Dec 2001 | $3.14 M(+83.9%) | $747.60 K(-13.0%) | $2.47 M(+1.5%) |
| Sept 2001 | - | $859.40 K(+18.6%) | $2.44 M(+33.2%) |
| June 2001 | - | $724.70 K(+406.4%) | $1.83 M(+21.7%) |
| Mar 2001 | - | $143.10 K(-79.9%) | $1.50 M(-11.8%) |
| Dec 2000 | $1.71 M(+21.8%) | $711.90 K(+182.4%) | $1.71 M(+71.6%) |
| Sept 2000 | - | $252.10 K(-36.6%) | $993.90 K(+34.0%) |
| June 2000 | - | $397.70 K(+15.6%) | $741.80 K(+115.6%) |
| Mar 2000 | - | $344.10 K | $344.10 K |
| Dec 1999 | $1.40 M | - | - |
FAQ
- What is United Therapeutics annual cost of goods sold?
- What is the all time high annual cost of goods sold for United Therapeutics?
- What is United Therapeutics annual cost of goods sold year-on-year change?
- What is United Therapeutics quarterly cost of goods sold?
- What is the all time high quarterly cost of goods sold for United Therapeutics?
- What is United Therapeutics quarterly cost of goods sold year-on-year change?
- What is United Therapeutics TTM cost of goods sold?
- What is the all time high TTM cost of goods sold for United Therapeutics?
- What is United Therapeutics TTM cost of goods sold year-on-year change?
What is United Therapeutics annual cost of goods sold?
The current annual cost of goods sold of UTHR is $257.50 M
What is the all time high annual cost of goods sold for United Therapeutics?
United Therapeutics all-time high annual cost of goods sold is $257.50 M
What is United Therapeutics annual cost of goods sold year-on-year change?
Over the past year, UTHR annual cost of goods sold has changed by +$105.90 M (+69.85%)
What is United Therapeutics quarterly cost of goods sold?
The current quarterly cost of goods sold of UTHR is $83.10 M
What is the all time high quarterly cost of goods sold for United Therapeutics?
United Therapeutics all-time high quarterly cost of goods sold is $83.10 M
What is United Therapeutics quarterly cost of goods sold year-on-year change?
Over the past year, UTHR quarterly cost of goods sold has changed by +$13.00 M (+18.54%)
What is United Therapeutics TTM cost of goods sold?
The current TTM cost of goods sold of UTHR is $304.80 M
What is the all time high TTM cost of goods sold for United Therapeutics?
United Therapeutics all-time high TTM cost of goods sold is $304.80 M
What is United Therapeutics TTM cost of goods sold year-on-year change?
Over the past year, UTHR TTM cost of goods sold has changed by +$59.50 M (+24.26%)